Endocyte -2.4% AH after pricing 4.5M-share offering at $21

|By:, SA News Editor

Endocyte's (ECYT) offering price is 9% below today's closing price of $23.07. The drug developer stands to reap gross proceeds of $94.5M, assuming the 675K-share overallotment option isn't exercised.

Shares had already fallen 15% over the last two trading days, following Endocyte's original offering announcement.